Related references
Note: Only part of the references are listed.TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
Kazuhito Naka et al.
NATURE (2010)
CD40 ligation converts TGF-β-secreting tolerogenic CD4-8- dendritic cells into IL-12-secreting immunogenic ones
Xueshu Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells
Ashley Hamilton et al.
EXPERIMENTAL HEMATOLOGY (2009)
Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-β signaling
Tomohiko Sato et al.
CANCER SCIENCE (2008)
Nilotinib: A Second-Generation Tyrosine Kinase Inhibitor for the Treatment of Chronic Myelogenous Leukemia
David L. DeRemer et al.
CLINICAL THERAPEUTICS (2008)
Targeted Drugs in Chronic Myeloid Leukemia
Joanna Gora-Tybor et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: A novel method in neural-hematopoietic axis
Michael Ricardo et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
The type III TGF-β receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation
Hye Jin You et al.
CARCINOGENESIS (2007)
Discovery of the Philadelphia chromosome: a personal perspective
Peter C. Nowell
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chronic myeloid leukaemia
Ruediger Hehlmann et al.
LANCET (2007)
Upregulation of the TGFβ signalling pathway by Bcr-Abl:: Implications for haemopoietic cell growth and chronic myeloid leukaemia
Gigi M. O. Moller et al.
FEBS LETTERS (2007)
Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells
Salem Akel et al.
PLATELETS (2007)
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide
David Shackelford et al.
CANCER RESEARCH (2006)
Evi1 is a survival factor which conveys resistance to both TGFb-β and taxol-mediated cell death via PI3K/AKT
Y. Liu et al.
ONCOGENE (2006)
Bcr-Abl activates the AKT/FoxO3 signalling pathway to restrict transforming growth factor-β-mediated cytostatic signals
A Atfi et al.
EMBO REPORTS (2005)
Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP
E Nitta et al.
ONCOGENE (2005)
Identification of binding sites of EVI1 in mammalian cells
B Yatsula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1
T Alliston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The role of internalization in transforming growth factor β1-induced Smad2 association with smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells
CE Runyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Smad4-independent regulation of p21/WAF1 by transforming growth factor-β
H Ijichi et al.
ONCOGENE (2004)
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice
H Fukasawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular mechanisms of leukemogenesis by AML1/EVI-1
K Mitani
ONCOGENE (2004)
The role of EVI1 in normal and leukemic cells
S Buonamici et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
TGFβ1 inhibits Ca2+-calcineurin-mediated activation in thymocytes
R Bommireddy et al.
JOURNAL OF IMMUNOLOGY (2003)
Transforming growth factor-beta inhibits human antigen-specific CD4(+) T cell proliferation without modulating the cytokine response
MM Tiemessen et al.
INTERNATIONAL IMMUNOLOGY (2003)
Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis
A Rosendahl et al.
INTERNATIONAL IMMUNOLOGY (2003)
c-Jun associates with the oncoprotein ski and suppresses Smad2 transcriptional activity
M Pessah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity:: SB-431542
NJ Laping et al.
MOLECULAR PHARMACOLOGY (2002)
The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells
V Senyuk et al.
ONCOGENE (2002)
Transforming growth factor-beta 1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects
M Marone et al.
LEUKEMIA (2002)
Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia
GM Cuenco et al.
ONCOGENE (2001)
Crystal structure of a phosphorylated Smad2:: Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-β signaling
JW Wu et al.
MOLECULAR CELL (2001)
A novel mechanism for regulating transforming growth factor β (TGF-β) signaling -: Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein, GIPC
GC Blobe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads
F Itoh et al.
EMBO JOURNAL (2001)
Oncogenic mechanisms of Evi-1 protein
H Hirai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Lefty inhibits receptor-regulated smad phosphorylation induced by the activated transforming growth factor-β receptor
L Ulloa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity
M Pessah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
K Izutsu et al.
BLOOD (2001)
Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins
M Fukuchi et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Signaling of transforming growth factor-β family members through Smad proteins
S Itoh et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling
X Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
Mechanisms of disease:: Role of transforming growth factor β in human disease.
GC Blobe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Smads as transcriptional co-modulators
L Attisano et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
Share Paper
